Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
1.83USD
23 Aug 2019
1.83USD
23 Aug 2019
Change (% chg)
$-0.21 (-10.29%)
$-0.21 (-10.29%)
Prev Close
$2.04
$2.04
Open
$2.03
$2.03
Day's High
$2.07
$2.07
Day's Low
$1.82
$1.82
Volume
121,700
121,700
Avg. Vol
156,378
156,378
52-wk High
$15.60
$15.60
52-wk Low
$1.82
$1.82
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 1.79 |
| Market Cap(Mil.): | $147.49 |
| Shares Outstanding(Mil.): | 49.16 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 98.31 | 33.85 |
| EPS (TTM): | -1.36 | -- | -- |
| ROI: | -41.22 | 7.52 | 12.69 |
| ROE: | -45.09 | 7.94 | 17.13 |
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates